Company · CIK 1827087
Vigil Neuroscience, Inc.
| CIK | 1827087 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-03-25 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-270710 | 2023-03-21 | 2025-08-07 | 3 | |
| 333-286243 | 2025-03-31 | 2025-08-07 | 3 | |
| 333-267672 | 2022-09-30 | 2022-10-14 | 2 | |
| 333-261230 | 2021-11-19 | 2022-01-10 | 4 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-08-07 | EFFECTDeclared effective | 333-286243 | 9999999995-25-002506 |
| 2025-08-07 | EFFECTDeclared effective | 333-270710 | 9999999995-25-002505 |
| 2025-04-08 | EFFECTDeclared effective | 333-286243 | 9999999995-25-001043 |
| 2025-03-31 | S-3Shelf registered | 333-286243 | 0001193125-25-067858 |
| 2023-03-30 | EFFECTDeclared effective | 333-270710 | 9999999995-23-000761 |
| 2023-03-21 | S-3Shelf registered | 333-270710 | 0001193125-23-075262 |
| 2022-10-14 | EFFECTDeclared effective | 333-267672 | 9999999995-22-003050 |
| 2022-09-30 | S-1Registration filed | 333-267672 | 0001193125-22-255476 |
| 2022-01-10 | 424B4Final prospectus | 333-261230 | 0001193125-22-005029 |
| 2022-01-06 | EFFECTDeclared effective | 333-261230 | 9999999995-22-000070 |
| 2022-01-03 | S-1/AAmendment | 333-261230 | 0001193125-22-000222 |
| 2021-11-19 | S-1Registration filed | 333-261230 | 0001193125-21-335145 |
| 2021-10-08 | DRSDraft made public | 377-05575 | 0000950123-21-013007 |